Innovative model predicts COVID-19 infection risk in the workplace
A collaboration of UK scientists have developed a cutting-edge predictive model that can accurately assess the risk of COVID-19 infection in office and school...
UVC: Examining the efficacy of the emerging disinfection technology
Gabriele Messina and Gabriele Cevenini of the University of Siena explore the emergence and efficacy of UVC disinfection technologies.
The onset of the COVID-19 pandemic...
Pfizer COVID vaccine demonstrates excellent efficacy against all variants
A novel study has revealed that two doses of the Pfizer COVID vaccine achieve 90% effectiveness against hospitalisations for at least six months against...
UK award substantial funding to safeguard adult social care this winter
The UK government has revealed that it will be providing considerable funding to support the adult social care sector throughout winter, a particularly challenging...
Exploring the issues surrounding vaccinating children against COVID-19
As the US and many European countries start vaccinating children against COVID-19, should more be done to prioritise those beyond our borders? Dominic Wilkinson,...
Shedding light on the world of UVC disinfection technologies
Tristan Williams, Technical Director of Finsen Tech Group outlines key aspects to consider when purchasing UVC disinfectant products.
Tristan Williams, Technical Director of Finsen Tech...
Effectively mitigating the impacts of mucormycosis
Martin Hoenigl, the President of the European Confederation of Medical Mycology, discusses the challenges of diagnosing and treating mucormycosis.
Mucormycosis is perhaps not a term...
Harnessing the benefits of UVA light treatment in COVID-19 patients
Following a first-in-human study which analysed the efficacy of UVA light treatment in COVID-19 patients, Health Europa spoke to Dr Ali Rezaie from the academic healthcare organisation, Cedars-Sinai, to find out more.
SARS-CoV-2 Delta variant causes twice the hospitalisations of Alpha
A novel study has revealed that the SARS-CoV-2 Delta variant may be the deadliest, demonstrating a two-fold increased risk of hospitalisation compared to the...
Trial begins for world-first multivariant COVID-19 vaccine booster
A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester.
Initiated by pharmaceutical company Gritstone, in partnership with...
XPhyto Therapeutics’ biosensors: taking rapid testing to the next level
Testing for coronaviruses may soon take no more than a couple of minutes thanks to XPhyto’s enzyme-based biosensor diagnostic technology.
A Canadian-headquartered life sciences company...
Innovative wound healing that utilises the body’s own defence system
Colzyx is developing a new generation of bioactive wound dressing that accelerates healing and combats infections, including those that are multi-drug resistant.
A novel medical...
Exploring the benefits of waterless bathing products
Infection prevention company GAMA Healthcare explains how innovative waterless bathing products could help to reduce the risk of infection transmission, improve patient care, and...
Combatting the pandemic of chronic wounds with Debrichem®
As COVID-19 shifted attention and medical resources from the community, chronic wounds are causing a pandemic of their own. However, DEBX Medical’s Debrichem® aims...
The Environmental Protection Agency: Safeguarding public health
The United States Environmental Protection Agency has a key role to play in ensuring only safe products reach the market, something of increasing importance...
COVID-19 variants will require infection control measures post-vaccination
Even after the implementation of widespread vaccination protocols, robust infection control measures will need to be enforced to prevent the spread of COVID-19 variants,...
Long COVID risk reduced by almost half after double vaccine dose
Receiving two COVID-19 vaccine doses reduces a person’s risk of experiencing long COVID by almost half, a new study has shown.
Research led by King’s...
COVID-19 vaccines are still effective against Delta variant, study confirms
Two COVID-19 vaccine doses provide the most effective protection from the Delta variant in the UK, a new study has shown.
Researchers from the University...
On-site vaccinations and phased return could make universities safer
Offering COVID-19 vaccines on campus and introducing phased returns in the autumn is key to making universities safer, public health experts have said.
In an...
Blueprint revealed for delivering hepatitis C treatment to drug users
An expert guide to delivering hepatitis C testing and treatment to people who inject drugs could help to eliminate the virus, scientists say.
Following a...
